iANTHUS CAPITAL HOLDINGS (ITHUF) Interest & Investment Income (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Interest & Investment Income came in at $254000.0 in Q1 2026, down 98.47% year-on-year from $16.6 million in Q1 2025, and down 54.07% quarter-over-quarter from $553000.0 in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Interest & Investment Income (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Interest & Investment Income across 7 years of filings, most recently posting $254000.0 for Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $254000.0, down 98.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 112.19% YoY), and the FY2025 annual result was $13.8 million, up 166.7% from the prior year.
- Interest & Investment Income came in at $254000.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $553000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $16.6 million in Q1 2025 to a low of -$3.9 million in Q2 2025.
- The 5-year median for Interest & Investment Income is $565000.0 (2023), against an average of $1.3 million.
- Peak annual rise in Interest & Investment Income reached 2442.02% in 2025, while the deepest fall reached 241.32% in 2025.
- iANTHUS CAPITAL HOLDINGS's Interest & Investment Income stood at $889000.0 in 2022, then tumbled by 71.09% to $257000.0 in 2023, then surged by 252.53% to $906000.0 in 2024, then tumbled by 38.96% to $553000.0 in 2025, then plunged by 54.07% to $254000.0 in 2026.
- The last three Interest & Investment Income figures came in at $254000.0 (Q1 2026), $553000.0 (Q4 2025), and $554000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 254,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254,000.00 |
| Dec 31, 2025 | 553,000.00 |
| Sep 30, 2025 | 554,000.00 |
| Jun 30, 2025 | -3.93 Mn |
| Mar 31, 2025 | 16.57 Mn |
| Dec 31, 2024 | 906,000.00 |
| Sep 30, 2024 | 817,000.00 |
| Jun 30, 2024 | 2.78 Mn |
| Mar 31, 2024 | 652,000.00 |
| Dec 31, 2023 | 257,000.00 |
| Sep 30, 2023 | 712,000.00 |
| Jun 30, 2023 | 296,000.00 |
| Mar 31, 2023 | 565,000.00 |
| Dec 31, 2022 | 889,000.00 |
| Sep 30, 2022 | 663,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 60,000.00 |
| Dec 31, 2021 | 146,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 109,000.00 |